AIA Group’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-36,833
Closed -$895K 337
2024
Q4
$895K Hold
36,833
0.02% 204
2024
Q3
$1.37M Hold
36,833
0.04% 196
2024
Q2
$1.75M Hold
36,833
0.05% 162
2024
Q1
$1.41M Hold
36,833
0.05% 179
2023
Q4
$1.15M Sell
36,833
-1,876
-5% -$67.4K 0.05% 186
2023
Q3
$1.56M Sell
38,709
-10,530
-21% -$493K 0.08% 121
2023
Q2
$2.59M Buy
49,239
+15,861
+48% +$966K 0.13% 79
2023
Q1
$2.13M Buy
33,378
+18,526
+125% +$1.21M 0.12% 81
2022
Q4
$721K Sell
14,852
-9,936
-40% -$623K 0.04% 177
2022
Q3
$1.75M Buy
24,788
+955
+4% +$81.7K 0.11% 79
2022
Q2
$1.69M Sell
23,833
-3,250
-12% -$209K 0.09% 92
2022
Q1
$2.16M Sell
27,083
-42,906
-61% -$3.2M 0.09% 101
2021
Q4
$6.39M Buy
69,989
+5,862
+9% +$629K 0.3% 47
2021
Q3
$8.24M Buy
64,127
+10,675
+20% +$1.49M 0.47% 44
2021
Q2
$7.08M Buy
53,452
+4,303
+9% +$567K 0.49% 41
2021
Q1
$5.18M Buy
49,149
+17,584
+56% +$1.76M 0.75% 41
2020
Q4
$3.47M Buy
+31,565
New +$2.31M 0.4% 41

Other funds holding STAA

AIA Group's STAA Position: Q1 2025 in Review

AIA Group sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 36,833 shares — an estimated $895K sold.

AIA Group first reported a position in STAA in Q4 2020 and held it in 17 quarters. The position peaked at $8.24M in Q3 2021. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • AIA Group reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • AIA Group sold 36,833 STAAR Surgical shares in Q1 2025, an estimated $895K.
  • AIA Group first reported a position in STAAR Surgical in Q4 2020 and held it in 17 quarters.
  • AIA Group's STAAR Surgical position peaked at $8.24M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on AIA Group's 13F filing for Q1 2025, filed 12 May 2025.